| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://www.decipherlabs.in | |
| Market Cap | 15.00 Cr. | |
| Enterprise Value(EV) | 18.44 Cr. | 2022-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 1.29 | Trailing Twelve Months Ending 2022-12 |
| Price-Earning Ratio (PE) | 11.75 | Trailing Twelve Months Ending 2022-12 |
| Industry PE | 32.17 | Trailing Twelve Months Ending 2022-12 |
| Book Value / Share | 24.86 | Trailing Twelve Months Ending 2022-12 |
| Price to Book Value | 0.61 | Calculated using Price: 15.10 |
| Dividend Yield | 0.00 | Period Ending 2022-03 |
| No. of Shares Subscribed | 1.01 Cr. | 10,100,000 Shares |
| FaceValue | 10 | |
| Company Profile | ||
| Combat is a professionally managed, well established public limited company, engaged in the manufacture & marketing of Pharmaceutical Formulations since its incorporation in 1986. The company has been marketing its branded formulations and entering into agreements with various companies for custom manufacturing and has grown to be known as a quality provider. | ||
| 1 Day |
|
+1.14% |
| 1 Week |
|
-6.85% |
| 1 Month |
|
-22.96% |
| 3 Month |
|
-52.44% |
| 6 Month |
|
-54.59% |
| 1 Year |
|
-74.23% |
| 2 Year |
|
-54.10% |
| 5 Year |
|
-25.25% |
| 10 Year |
|
-83.22% |
| 5 years | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
| Return on Equity (%) | 8.60 | 17.45 | 14.59 | 10.69 | 60.15 | |
| Return on Capital Employed (%) | 8.10 | 17.95 | 18.11 | 13.09 | 40.71 | |
| Return on Assets (%) | 6.16 | 8.71 | 5.28 | 3.79 | 28.24 |
| Particulars | 6 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
| Shh. Funds | 2 | 3 | 13 | 14 | 24 | 33 | |
| Non Curr. Liab. | 1 | 8 | 7 | 0 | |||
| Curr. Liab. | 1 | 4 | 21 | 17 | 11 | 9 | |
| Minority Int. | |||||||
| Equity & Liab. | 3 | 6 | 35 | 39 | 42 | 42 | |
| Non Curr. Assets | 0 | 13 | 16 | 4 | 6 | ||
| Curr. Assets | 3 | 6 | 23 | 23 | 38 | 36 | |
| Misc. Exp. not W/O | |||||||
| Total Assets | 3 | 6 | 35 | 39 | 42 | 42 |
| Particulars | 6 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-12 Rs. Cr. TTM |
| Net Sales | 1 | 8 | 24 | 56 | 65 | 59 | |
| Other Income | 0 | 0 | 1 | 8 | 7 | ||
| Total Income | 1 | 8 | 24 | 56 | 73 | 66 | |
| Total Expenditure | -1 | -8 | -21 | -52 | -59 | -61 | |
| PBIDT | 0 | 0 | 3 | 4 | 14 | 5 | |
| Interest | 0 | -1 | -1 | 0 | -1 | ||
| Depreciation | -1 | -1 | -1 | -1 | |||
| Taxation | 0 | 0 | -1 | -1 | -1 | ||
| Exceptional Items | -2 | ||||||
| PAT | 0 | 0 | 1 | 1 | 11 | 1 | |
| Minority Interest | |||||||
| Share Associate | |||||||
| Other Related Items | |||||||
| Consolidated Net Profit | 0 | 0 | 1 | 1 | 11 | 1 | |
| Adjusted EPS | 0 | 1 | 1 | 1 | 11 | 1 |
| Particulars | 5 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
| Cash Fr. Operatn. | 0 | 0 | -15 | 2 | 8 | |
| Cash Fr. Inv. | 0 | 0 | 0 | 0 | ||
| Cash Fr. Finan. | 0 | 0 | 16 | 4 | 1 | |
| Net Change | 0 | 0 | 1 | 6 | 9 | |
| Cash & Cash Eqvt | 0 | 0 | 1 | 7 | 15 |
|
Tue, 28 Mar 2023
Closure of Trading Window Closure of trading window |
|
Mon, 06 Mar 2023
Board Meeting Outcome for Outcome Of The Board Meeting Held On 06.03.2023 Outcome of the Board meeting held on 06.03.2023 |
|
Mon, 06 Mar 2023
Re-Constitution Of The Committees Re-constitution of the Committees |
| Wed, 29 Mar 2023 |
Opening at High
|
Making Lower Lows for 3 days
|
Close Within 52 Week Low Zone
|
Close Below Last Week Low
|
Close Below Last Month Low
|
Equities
M.F.
Sectors